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EDITORIAL
HGF and extracellular matrix turnover in normal human
glomeruli ex vivo
Hepatocyte growth factor (HGF) and its receptor, c-
met, are present in many tissues. While the responses
that they mediate are generally that of cell proliferation
and maturation, the exact pathways involved, and the
responses generated, are specific to both organs and the
cell types contained therein. They also vary by the stage
of development or maturity of the organism. For instance,
HGF is required for liver development in the embryo [1].
In the adult, it is an adipokine with a strong association
with components of the metabolic syndrome [2].
Glomerulosclerosis is a histologic description of
changes in the glomerular extracellular matrix, princi-
pally manifest by a local or generalized increase in its
amount. Because scarring is the major histologic feature
associated with glomerulosclerosis, the fact that it is a
dynamic process has often been underappreciated. Re-
cent studies have emphasized that fact that glomerular
scarring is not a “final common pathway”; rather, it is an
active process that has a wide variety of underlying eti-
ologies and rates of expression and progression [3]. There
are a number of unanswered questions about glomeru-
losclerosis, including what determines susceptibility, rate
of progression, distribution of the lesions, and the means
to induce stabilization or regression of the lesions.
The report by Esposito et al [4] in this issue of Kid-
ney International addresses the question of the potential
reversibility of glomerulosclerosis. They make use of re-
nal biopsies from transplant donor kidneys immediately
prior to transplant. They show that the addition of HGF
to media in which freshly isolated glomeruli are placed
results in decreased in the expression of type IV collagen
mRNA, and secretion of the protein into the medium.
There are also decreases in other molecules that might
be expected when the turnover of extracellular matrix
favors a reduction in the amount of newly formed ma-
trix. These include a decrease in the amount of TGF-b ,
a prosclerotic cytokine, and a decrease in the amount of
an inhibitor of matrix metalloproteinases (TIMP-1). Im-
portantly, the amount of matrix proteinases that degrade
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glomerular extracellular matrix, MMP-2, and MMP-9,
were not changed. Thus, the net balance was toward a
decrease in the synthesis of glomerular extracellular ma-
trix, and an increase in the degradation of extracellular
matrix. These findings are important for the reasons that
they are results obtained with human tissues, and they
underscore that fact that glomerular extracellular matrix
turnover is a very dynamic process that is capable of being
manipulated by the addition of pharmaceutical agents.
This is not the first report of the use of glomeruli iso-
lated from human renal biopsies for study of extracel-
lular matrix turnover [5]. These previous studies, and a
large body of literature from animal models, support the
underlying premise of this study, namely, that glomeru-
losclerosis is associated with increased levels of molecules
involved in the production of extracellular matrix, and/or
decreased expression of those involved with its degrada-
tion [6]. However, because these studies were necessarily
cross-sectional, and static in nature, they left open the
question of whether the findings were simply reflective
of the state of the disease, or whether they played a di-
rect role in the regulation of glomerular extracellular ma-
trix turnover. In addition, they left open the question of
whether their expression could be regulated by extrinsic
factors. The Esposito paper provides the answers to these
questions, in part. Namely, it would appear that the addi-
tion of HGF alters extracellular matrix molecular profiles,
at both the mRNA and protein levels, in a manner that
would favor lesion resolution.
There are several important caveats that must be kept
in mind when evaluating this report for its generaliza-
tion to the general population and the pathogenesis of
glomerulosclerosis. First, the number of biopsies was
small (5 in number). Second, the biopsies were from ap-
parently normal kidneys. This latter point is particularly
important because it has been clearly established that
the susceptibility to glomerulosclerosis and the rate at
which it progresses has a strong genetic undercurrent.
Thus, a study of normal glomeruli may not directly apply
to glomeruli that are scarring. In fact, it is conceivable
that the responses might be opposite to what one might
expect or wish.
In addition, while the glomerulus is important in the de-
velopment of glomerulosclerosis, it has long been known
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that the significance of glomerular lesions in the loss of
renal function is overshadowed by changes in the tubu-
lointerstitial compartments [7]. Because the authors also
had access to these areas of the kidney in the biopsies,
one would hope that the next studies in this area would
take advantage of this fact.
Finally, because the glomeruli under study were placed
in tissue culture for 24 to 48 hours, they lacked several
factors that could greatly affect glomerular extracellular
matrix turnover, the most important of which include a
blood supply with its attendant hydrostatic force and the
delivery of adequate oxygenation.
Thus, HGF may play an important role in the stabiliza-
tion or reduction of glomerulosclerosis, as suggested by
the pioneering study by Esposito et al [4] in the current
issue. One, therefore, might expect this report to signal
the beginning of a series of studies concerning the dynam-
ics of extracellular matrix turnover in the glomerulus and
other kidney structures.
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